Cyclic tailor-made amino acids in the design of modern pharmaceuticals

被引：47
作者：
Liu, Jiang [1 ]
Han, Jianlin [1 ]
Izawa, Kunisuke [2 ]
Sato, Tatsunori [2 ]
White, Sarah [3 ]
Meanwell, Nicholas A. [4 ]
Soloshonok, Vadim A. [5 ,6 ]
机构：
[1] Nanjing Forestry Univ, Coll Chem Engn, Jiangsu Coinnovat Ctr Efficient Proc & Utilizat F, Nanjing 210037, Jiangsu, Peoples R China
[2] Hamari Chem Ltd, Higashi Yodogawa Ku, 1-4-29 Kunijima, Osaka 5330024, Japan
[3] Oakwood Chem Inc, 730 Columbia Hwy N, Estill, SC 29918 USA
[4] Bristol Myers Squibb Res & Early Dev, Dept Small Mol Drug Discovery, POB 4000, Princeton, NJ 08543 USA
[5] Univ Basque Country UPV EHU, Fac Chem, Dept Organ Chem 1, Paseo Manuel Lardizabal 3, San Sebastian 20018, Spain
[6] Basque Fdn Sci, IKERBASQUE, Maria Diaz Haro 3,Plaza Bizkaia, Bilbao 48013, Spain
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2020年 / 208卷
基金：
中国国家自然科学基金;
关键词：
Cyclic amino acids; Tailor-made amino acids; Drug design; Pharmaceuticals and medicinal formulations; DIPEPTIDYL-PEPTIDASE-IV; MICHAEL ADDITION-REACTIONS; GLUCAGON-LIKE PEPTIDE-1; OREXIN RECEPTOR ANTAGONISTS; SCALE ASYMMETRIC-SYNTHESIS; HCV PROTEASE INHIBITOR; POLY(ADP-RIBOSE) POLYMERASE PARP; DIELS-ALDER REACTION; SELF-DISPROPORTIONATION; NI(II) COMPLEXES;
D O I：
10.1016/j.ejmech.2020.112736
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Tailor-made AAs are indispensable components of modern medicinal chemistry and are becoming increasingly prominent in new drugs. In fact, about 30% of small-molecule pharmaceuticals contain residues of tailor-made AAs or structurally related diamines and amino-alcohols. Cyclic tailor-made AAs present a particular value to rational structural design by virtue of their local conformational constraints and are widely used in lead optimization programs. The present review article highlights 34 compounds, all of which are derived from cyclic AAs, representing recently-approved, small-molecule pharmaceuticals as well as promising drug candidates currently in various phases of clinical study. For each compound, the discussion includes the discovery, therapeutic profile and optimized synthesis, with a focus on the preparation of cyclic tailor-made AA as the principal structural feature. The present review article is intended to serve as a reference source for organic, medicinal and process chemists along with other professionals working in the fields of drug design and pharmaceutical discovery. (c) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：74
相关论文
共 344 条
  • [21] Recent progress in sodium channel modulators for pain
    Bagal, Sharan K.
    Chapman, Mark L.
    Marron, Brian E.
    Prime, Rebecca
    Storer, R. Ian
    Swain, Nigel A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (16) : 3690 - 3699
  • [22] Biology of incretins: GLP-1 and GIP
    Baggio, Laurie L.
    Drucker, Daniel J.
    [J]. GASTROENTEROLOGY, 2007, 132 (06) : 2131 - 2157
  • [23] Bahekar R., 2011, Short Chain Peptidomimetics Based Orally Active GLP-1 Agonist and Glucagon Receptor Antagonist, Patent No. [WO2011048614A2., 2011048614]
  • [24] Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance
    Bai, Peter
    [J]. MOLECULAR CELL, 2015, 58 (06) : 947 - 958
  • [25] Novel Ligands Targeting α4β1 Integrin: Therapeutic Applications and Perspectives
    Baiula, Monica
    Spampinato, Santi
    Gentilucci, Luca
    Tolomelli, Alessandra
    [J]. FRONTIERS IN CHEMISTRY, 2019, 7
  • [26] Development of a Manufacturing Route to Avibactam, a β-Lactamase Inhibitor
    Ball, Matthew
    Boyd, Alistair
    Ensor, Gareth J.
    Evans, Matthew
    Golden, Michael
    Linke, Simon R.
    Milne, David
    Murphy, Rebecca
    Telford, Alex
    Kalyan, Yuriy
    Lawton, Graham R.
    Racha, Saibaba
    Ronsheim, Melanie
    Zhou, Shao Hong
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2016, 20 (10) : 1799 - 1805
  • [27] Process development for ABT-472, a benzimidazole PARP inhibitor
    Barkalow, Jufang H.
    Breting, Jeffrey
    Gaede, Bruce J.
    Haight, Anthony R.
    Henry, Rodger
    Kotecki, Brian
    Mei, Jianzhang
    Pearl, Kurt B.
    Tedrow, Jason S.
    Viswanath, Shekhar K.
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2007, 11 (04) : 693 - 698
  • [28] Baskaran S., 2011, Chemical Compounds, Patent No. [WO2011091446, 2011091446]
  • [29] An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals
    Baumann, Marcus
    Baxendale, Ian R.
    Ley, Steven V.
    Nikbin, Nikzad
    [J]. BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2011, 7 : 442 - 495
  • [30] Belema M., 2011, Preparation of Biphenyls End-Capped with Amino Acid or Peptide Derivatives as Hepatitis C Virus Inhibitors, Patent No. [WO 2011075439 A1, 2011075439]
12345678910